chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started experiencing skin rash in face and flushing about two weeks after the vaccine about three times and had to take a Benadryl each time for the reaction even while being on Zyrtec on a regular basis. I started having under eye puffiness and body rashes right after these reactions that didn't go away even with regular allergy medication. I then started having a reaction similar to a nut allergy even though I ate something I made at home that had no nuts. I had some swelling on the right side of my face and eye. I also had some minor lip swelling and itching along with throat tightness. I had to take a Benadryl as well with this reaction. I have experienced episodes of this type everyday after eating or just in general and I'm on a high histamine regimen as prescribed by the doctor. I was placed on steroids Prednisone for three days with no results after that. I have episodes where I feel my throat swelled and tightness along with itchy swelled lips, nasal pressure and itchy body.  I'm still taking the his histamines as prescribed and Benadryl when the bad reactions occur. I have a epi pen.
MMR II was reconstituted with Normal Saline (0.9%) instead of the supplied Merck Diluent and was administered to a patient; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 16-APR-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot # S035356, expiry date 05-NOV-2021 (dose, route of administration, anatomical location were not provided), reconstituted with sodium chloride (normal saline) 0.9 %, lot # 9Y3L4, expiry date 20-MAY-2021 (dose, route of administration were not reported), despite sterile diluent (strength, dose, route of administration, lot # and expiry date were not provided) for prophylaxis.
Fainted after Twinrix, TB skin test, and RPR drawn. Pt unresponsive 2-5 seconds, alert and oriented x 4, B/P 120/74 p-74, vomited one time, pt did not feel comfortable walking to car. Ambulance called, after EMS arrived, pt began to feel better and assisted to private vehicle, stating I feel fine now.
became unresponsive after receiving her first dose of Pfizer Vaccine .  Smelling salts were applied and patient quickly became responsive.  Patient was given 4 oz of apple juice which she tolerated well.  Also complained of loss of hearing/smell and feeling flushed. Patient had no difficulty breathing and or rash. 911 was called and patient subsequently was sent to ER for further evaluation.
Fever, chills, body aches, headache, last about 24 hours. Treated with Tylenol and Ibuprofen.
Mild cough, then extreme nausea and vomiting for approx. 2 hours. Followed by fever/chills and muscle soreness.
HEADACHES, DISINESS, MEMORY LOSS, PAIN IN JOINTS, TRICK JOINTS, HAIR LOSS
Bump on same arm but on shoulder blade; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Bump on same arm but on shoulder blade) and VACCINATION SITE PAIN (Pain at injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (Bump on same arm but on shoulder blade) and VACCINATION SITE PAIN (Pain at injection site). The patient was treated with IBUPROFEN for Root canal procedure, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Bump on same arm but on shoulder blade) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-078103 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-078103:Dose 1
COVID-19 (vaccination failure); COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 as dose 4 (booster), single (Lot number: GH9693) at the age of 33 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 16Mar2021 as dose 1, single (Lot number: EN6207), in left arm, on 06Apr2021 as dose 2, single (Lot number: ER8734), in left arm and on 20Nov2021 as dose 3 (booster), single (Lot number: FG3527), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Peanut allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Augmentin, reaction(s): "Allergy". The following information was reported: COVID-19 (medically significant) with onset Sep2023, outcome "unknown"; VACCINATION FAILURE (medically significant) with onset Sep2023, outcome "unknown", described as "COVID-19 (vaccination failure)". Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient was treated with nirmatrelvir, ritonavir (PAXLOVID), from 29Sep2023 to 03Oct2023.
Vomiting within 3 hours of shot - 1st day 2nd and 3rd day - crippling abdominal pain
Patient stated that he was feeling lightheaded, weak and had a headache. Patient asked to sit down and blood pressure was taken at approx. 1:55 pm (110/70). Patient given water to drink and two fig bars, which he drank and ate. BP rechecked at approx 2:00 pm (90/60). Patient still stated feeling weak and headache. BP rechecked at 2:04 pm (91/58) and glucose was 156. BP rechecked at approx 2:15pm (101/64). Patient states he is feeling better but still has a headache. Mom instructed to take him to be seen immed. if symptoms persist or get worse but he could be given TYLENOL for headache, fever or pain. Patient's mother called on 6/25/15, patient reports soreness in right arm but no other symptoms.
no adverse event; Nurse reported PROQUAD was administered after TE; see TE case 02487539. See full details below. No additional AE/no PQCs.    ?    Names of vaccines involved PROQUAD X007537 09/08/2024        ?    Temperature 8.1°F        ?    Time frame 3 hour; This spontaneous report as received from a nurse refers to a patient of unknown age and gender.     The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 21-SEP-2023, the patient was vaccinated with an improperly stored 1 dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot# X007537, expiration date: 08-SEP-2023 (exact dose, route of administration and anatomical location were not reported) for prophylaxis.        Administered dose of vaccine was exposed to the temperature excursion of 8.1 degrees Fahrenheit for 3 hours (product storage error). No previous temperature excursion had occurred. There were no additional adverse events reported (no adverse event).  Lot number X007537 has been verified to be a non-valid lot number for V221.
No side effects until this orning, day #8.  My arm at the injection site has been itching and the area is about a 3-4 inch oval, red and swollen.  Not painful, just itchy.
11/25 Pt ot ED history of angina, chronic back pain, CHF, CVA, diabetes mellitus, reflux disease, hypertension, obstructive sleep apnea, seizure disorder and TIA reportedly more sleepy than usual. EMS was called. The patient's blood sugar was 55, she was given oral glucose and her blood sugars in the 90s on arrival. The patient's blood pressures noted to be low. She states that she just got out of rehabilitation one week ago. The old record was reviewed. The patient was admitted 10/11/2021 to 10/25/2021 with acute renal failure, hypoglycemia, diabetes mellitus, leg pain, workup for pheochromocytoma was negative. She went to subacute rehabilitation and 10/25/2021. She states while there she did contract Covid 19. ... 11/27 Today, the patient is doing well.  No cough.  No congestion.  The patient now is on isolation, because she tested positive for coronavirus.  The patient readmitted because of acute renal failure and Nephrology was consulted.  On top of that, patient has hypoglycemia and that is why we are going to consult Endocrinology and also continue with fluid to improve her renal function  11/29 The patient is currently on room air.  The patient has been positive for COVID for more than 2 weeks.  So for now, we will keep the patient off any treatment for COVID and we will follow up accordingly.  12/3 The patient is currently on room air.  The patient has been positive for COVID for more than 2 weeks.  So for now, we will keep the patient off any treatment for COVID and we will follow up accordingly..... Discharged  12/10  Patient presents to the Ed with CC of hypoglycemia. EMS stating patient BS read low. Patient received 2 tubes of oral glucose per ems patient repeat bs was 52. Upon arrival patient BS was 20mg/dl. Patient BP 98/52. Patient deniesd any pain. Pt had + covid test 11/26/21 12/11 Pt with lethargy this date. Pt would benefit from skilled OT to increase safety and independence in ADLs and mobility, recommend SAR vs. HHC with supervision assist pending pt progress.  12/13 Patient currently on RA, sating high 90s
doses given after temperature excursion; Product storage error; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported   No treatment information was provided
Pt. broke out in rash around face/head area within 10 min of administration. Notified MD, gave 2.5 mL po BENADRYL as ordered & monitored pt for 15-20 min after administration of BENADRYL.
Rash on right mid-back, 3" diameter, round, itching - just above waistline, red-spots inside. Red eyes.
This spontaneous report as received from a healthcare professional who was a quality control representative of a company refers to an unspecified number of patients of unknown age and gender. Doses of PEDVAXHIB that were exposed to a temperature excursion on an unspecified date may had been administered to unspecified patients (lot#, dose, dose# and route not reported) on unspecified dates since the temperature excursion. He stated that some of the improperly stored doses were administered to some patients, but he was certain that the practices that administered the doses reported the administration to Merck to request revaccination information. He was not able to provide any healthcare provider information or case numbers, nor could he provide any additional information about these scenarios. He confirmed that he was aware that the administration of improperly-stored products to patients posed a safety risk to the patients. He did not know whether or not there had been any adverse effects. This is one of several reports received from the same source. Additional information is not expected as there was no consent for follow up contact.
Pfizer-BioNTech Covid-19 vaccine eua  Evening of getting the second shot body aches started. The following evening still having body aches, inability to focus/brain fog, swollen and sore injection site
Information has been received from a health professional concerning a 7 year old female, with no medical history and no allergies, who on 13-JUN-2000 was vaccinated with a dose of Varivax. There was no concomitant medication. On 05-OCT-2006 the patient came to the office showing 15 lesions on her back. At the time of the report the report the patient was recovering. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought.  No product quality complaint was involved. Additional information has been requested.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patients' medical history was not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # reported as L025207, expiration date reported as 07-JUL-2017, lot #  L008273, expiration date reported as 11-MAR-2016, lot # L002871, expiration date reported as 27-JAN-2016, lot # K026385, expiration date reported as 15-DEC-2016. No adverse effect was reported. This is one of several reports from the same report. Additional information has been requested.
loss of concentration; lost 25 pounds; While driving his car he pushed the gas pedal instead of break, mental confusion; Something had screwed up in his brain, he has loss of coordination; motor skills have been affected; Memory loss; This spontaneous case was reported by a consumer and describes the occurrence of DISTURBANCE IN ATTENTION (loss of concentration), WEIGHT DECREASED (lost 25 pounds), CONFUSIONAL STATE (While driving his car he pushed the gas pedal instead of break, mental confusion), COORDINATION ABNORMAL (Something had screwed up in his brain, he has loss of coordination) and MOTOR DYSFUNCTION (motor skills have been affected) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISTURBANCE IN ATTENTION (loss of concentration), WEIGHT DECREASED (lost 25 pounds), CONFUSIONAL STATE (While driving his car he pushed the gas pedal instead of break, mental confusion), COORDINATION ABNORMAL (Something had screwed up in his brain, he has loss of coordination), MOTOR DYSFUNCTION (motor skills have been affected) and AMNESIA (Memory loss). At the time of the report, DISTURBANCE IN ATTENTION (loss of concentration), WEIGHT DECREASED (lost 25 pounds), CONFUSIONAL STATE (While driving his car he pushed the gas pedal instead of break, mental confusion), COORDINATION ABNORMAL (Something had screwed up in his brain, he has loss of coordination), MOTOR DYSFUNCTION (motor skills have been affected) and AMNESIA (Memory loss) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Investigation: no signs of stroke (normal) No signs of stroke.         The symptoms started after the second dose, within 5 days to a week of it. Patient experienced 25 pound weight loss, loss of motor skills, loss of concentration, coordination and confusion during daily activities.  The patient received medical exams and they showed no signs of stroke. The symptoms are gradually resolving.  No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
16cm x 14cm are of erythema on left deltoid area and also pruritis, warmth. On 04/03/2002 these symptoms started. On 04/01/2002 DTaP injection give at left deltoid.
Dermatitis to left and right upper arms. Claritin and hydrocortisone used. No relief. Began getting worse over the weekend. Zyrtec and hydrocortisone used and no relief. Now spreading to torso and lower arms. Very itchy.  Primary care is starting prednisone.  Claritin 1/8 zyrtec  1/11 hydrocortisone 1/8-1/11
This spontaneous report as received from a consumer refers to a patient of unknown age who has had joint pain for arthritis. On an unknown date the patient was vaccinated with ZOSTAVAX and the joint pain for arthritis got worst after vaccine was given. Patient outcome was unknown. Additional information is not expected.
nausea, h/a, rt arm weak, swollen hot, aching-cannot use-hand;feels numb-temp up into neck;
This case was reported by a nurse via sales rep and described the occurrence of swelling arm in a 4-year-old male patient who received KINRIX (batch number 53NB2, expiry date 10th November 2018). On 15th August 2017, the patient received KINRIX. On 17th August 2017, 2 days after receiving KINRIX, the patient experienced swelling arm, erythema of extremities and rash. In August 2017, the outcome of the swelling arm, erythema of extremities and rash were recovered/resolved. The reporter considered the swelling arm, erythema of extremities and rash to be almost certainly related to KINRIX. Additional details were reported as follows: The patient received KINRIX in the left deltoid. The patient experienced huge red, swollen rash that covered most the arm. The patient did not require emergency room or doctor visit. The healthcare professional gave her consent for follow up. The case was linked to US2017130471, reported by the same reporter.
Patient complained of fever, headache, nausea & weakness. Also felt shaky (for about two hours). All other sx cleared up within two to three days.
death certificate recv by hlth dept 30JUL;pt recv vax 25JUL98 per nurse @ local hosp;pt arrived DOA per pathologist probable cause of death SIDS;
#Right parietal/temporal subarachnoid hemorrhage and right intra-axial hemorrhage  CT brain (1/12/21): Right parietal intra-axial hemorrhage toward the convexity measuring 2.3 x 1.1 x 1.7 cm with decompression into the subarachnoid space, mild right predominantly temporal and parietal subarachnoid hemorrhage is seen with minimal associated hemorrhage along the tentorium. Mild diffuse right cerebral sulcal effacement with minimal leftward midline shift measuring 2.5 mm. #Dural sinus thrombosis  CTA head (1/11/21): Increased density within the superior sagittal sinus, inferior  sagittal sinus, and transverse sinuses on noncontrasted images  with no flow seen on postcontrast sequences consistent with  venous sinus thrombosis #Left sided weakness 2/2 above #Recent jaw alignment procedure
anaphylactic rxn w/angioedema & wheezing;tx w/DPH, Aristocort, Epi & observation;
Extremely dizzy any time she moves her head or body was reported as worsened; Extremely dizzy any time she moves her head or body was reported as worsened; This is spontaneous report received from a contactable consumer (patient). A 25-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: FA6780), dose 1 via an unspecified route of administration, administered in arm right on 08Jul2021 (at a age of 25-year-old) as DOSE 1, SINGLE for Covid-19 immunisation. The patient medical history was reported as none and patient's concomitant medications were not reported. The patient was just extremely dizzy any time she moves her head or body. It was just horrible. It started approximately a day and a half to 2 days after she had the shot. It was in the early morning she believes. The extremely dizzy any time she moves her head or body was reported as worsened on an unspecified date of 2021. No investigation assessment was present. No additional vaccines administered on same date of the Pfizer suspect. AE did not require a visit to emergency room and physician office. There was no prior vaccinations within 4 weeks and there was no AE(s) following prior vaccinations. The outcome of event was not recovered.
like having a heart attack; my throat was numb.; It was extreme like after the reflex like pain in my chest; I was having Heart pressure and my heart and my jaw and my throat was numb.; anxiety; my jaw was numb; Booster; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received third dose of bnt162b2 (Batch/Lot Number: FF2587, Expiration date: Unknown, age at the time of vaccination: 71-year-old) via an unspecified route of administration, administered in left upper arm on an unspecified date as DOSE 3 (BOOSTER), SINGLE for covid-19 immunization. Medical history included cancer (have cancer two years ago) and high blood pressure; both from an unknown date and unknown if ongoing. Concomitant medications included letrozole taken for cancer (A chemo pill, To prevent the cancer from coming back), start and stop date were not reported; lisinopril taken for high blood pressure, start and stop date were not reported. The patient previously received bnt162b2 (Batch/Lot Number: EN5318), via an unspecified route of administration, administered in left upper arm on 08Feb2021 (age at vaccination was 70 years) as DOSE 1, SINGLE and bnt162b2 (Batch/Lot Number: EN6198), via an unspecified route of administration, administered in left upper arm on 01Mar2021 (age at vaccination was 71 years) as DOSE 2, SINGLE for covid-19 immunization and experienced like having a heart attack, my throat was numb, It was extreme like after the reflex like pain in my chest, I was having Heart pressure and my heart and my jaw and my throat was numb, my jaw was numb, anxiety. The patient reported that she had adverse reaction Pfizer her second vaccination and exactly the same reaction to the booster. On an unspecified date, the patient received booster dose and the patient was having heart pressure and her heart and jaw and throat was numb. She stated that it was extreme like after the reflex like pain in her chest and numbing in her throat and in her jaw like having a heart attack. When asked about the corrective therapy, the patient reported that she just gave three medication that she was on, because of her cancer. She take Cannabis Mint and anti anxiety at night, a pill, So when she had those adverse effect because at that she was having Heart pressure and her heart and her jaw and her throat was numb so she took a CBD to relax her body to the anxiety after almost a hour it come down. She took Xanax and CBD Mint 2.5 milligram. Petra Kiera Concession Cannabis infused Mint and she have one more pill the anti anxiety pill was Xanax and its 0.5 milligram and alprazolam. The patient underwent lab tests and procedures which included comprehensive metabolic panel, CBC and another differential, Cancer antigen with unknown results on 26Oct2021. Therapeutic measures were taken as a result of the events. Investigation assessment was reported. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.